Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Obesity
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Obesity
    Obesity in Elders Increases Risk of Disability, Not Risk of Death - (DGNews)
    High BMI Increases Risk of Colorectal Adenomas - (DGNews)
    Obesity Raises Risk of GERD - (DGNews)
    TopAbstracts in Obesity 08/19/2008 - (DGNews)
    Surgical Weight Loss Fails to Improve Sleep Apnoea - (DGNews)

    News archive

     Recent webcasts/CME - Obesity
    • Incretin-Based Therapy in Diabetes: Expanding Options and Providing Benefits
    • Assessing Recent Data on Incretin-Based Therapy in Diabetes
    • Cardiometabolic Risk and Risk Management
      Understanding Metabolic Syndrome: Knowing the Risks
      Obesity, Type 2 Diabetes, and Cardiovascular Disease

      Webcasts/CME archive

       Recent cases - Obesity
        Reconstruction of the Gastric Passage by a Side-To-Side Gastrogastrostomy After Failed Vertical-Banded Gastroplasty: A Case Report
        Perforated Appendicitis Masquerading as Acute Pancreatitis in a Morbidly Obese Patient.
        Giant Serous Cystadenoma Arising from an Accessory Ovary in a Morbidly Obese 11-Year-Old Girl: A Case Report
        Consideration of Polypharmacology in Regards to Effective Weight Reduction: A Patient on Diabetes Medication
        Consideration of Polypharmacology in Relation to Effective Weight Reduction: A Patient on Antipsychotic Medication

        Cases archive
          




        my personal edition > obesity > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Obese Individuals May Be More Susceptible To Altitude Sickness

        DALLAS, TX -- August 20, 2003 -- Obese individuals traveling to a high-altitude destination should take extra precautions, according to researchers at UT Southwestern Medical Center at Dallas and the Institute for Exercise and Environmental Medicine.

        In a study conducted at the institute, a joint venture between UT Southwestern and Presbyterian Hospital of Dallas, researchers report that obesity may be associated with the development of acute mountain sickness (AMS), which is often caused by rapid ascent to altitudes of 2,500 meters, or 8,250 feet, above sea level. Symptoms include headache, nausea and vomiting, fatigue, weakness, dizziness, lightheadedness and sleep disorders.

        The researchers' findings, reported in today's issue of Annals of Internal Medicine, also suggest that impaired breathing during sleep may be related to increased levels of AMS in obese individuals.

        "Based on the results from our study, obesity may be an important factor in the development of acute mountain sickness," said Dr. Tony G. Babb, assistant professor of internal medicine at UT Southwestern and the study's senior author.

        "We recommend that when traveling to high altitudes obese individuals, even those without a history of AMS, take precautions to ensure a slow, gradual ascent," Dr. Babb said. "In addition, these individuals should consider taking the prescription medication acetazolamide, which has been effective in preventing altitude sickness in susceptible travelers."

        The study included nine obese men and 10 nonobese men who spent 24 hours in a decompression chamber. The barometric pressure was held steady at the equivalent to an altitude of 3,658 meters, or about 12,000 feet. Study participants completed an AMS self-report questionnaire that measured symptoms associated with altitude sickness at sea level and during decompression. Symptoms were measured at six hours, 12 hours and 24 hours.

        Seventy-eight percent of obese study participants - seven individuals - developed AMS after the 24-hour exposure. Of the nonobese study participants, 40 percent (four) reported significant AMS symptoms.

        "Symptoms of altitude sickness were more severe in the obese study participants, which indicates the occurrence of AMS may be closely related to increased body weight," Dr. Babb said.

        Acute mountain sickness usually occurs in individuals exposed to an altitude exceeding 2,500 meters who have not acclimated themselves to the altitude before engaging in physical activities. Symptoms usually appear within 12 to 24 hours. Mountain climbers, trekkers, skiers and travelers to high-altitude destinations like the Andes or Himalayas are at greatest risk.

        Other researchers contributing to the study were Dr. Ge Ri-Li, lead author of the study and former fellow at the Institute for Exercise and Environmental Medicine; Dr. Benjamin Levine, professor of internal medicine at UT Southwestern and medical director of the institute; and researchers at the Institute for Exercise and Environmental Medicine.

        The study was funded by the American Lung Association and the U.S. Wilderness Medical Society.


        SOURCE: UT Southwestern Medical Center



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send